Related Experiment Video
Updated: May 19, 2026

Quantitative Measurement of Invadopodia-mediated Extracellular Matrix Proteolysis in Single and Multicellular Contexts
Published on: August 27, 2012
PCIF1 modulates glioblastoma cell migration and invasion by altering PI(3,4)P2 levels through the PI5-phosphatase
Preethi Priyanka Musunuru1,2, Yihan Li1,2, Yu Zhou1,2
1Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
Abstract:
Phosphorylated CTD Interacting Factor 1 (PCIF1) is the exclusive methyltransferase responsible for the N6,2-O-dimethyladenosine (m6Am) modification in mammalian mRNA. Our previous research identified PCIF1 as a potent tumor suppressor in glioma, demonstrating its ability to impair cell proliferation, induce G2/M phase arrest, and promote apoptosis. However, its role in glioma cell migration and invasion remains unclear. In this study, we investigate how PCIF1 regulates glioma cell migration and invasion. Overexpression of PCIF1 inhibits migration and invasion, whereas PCIF1 knockdown enhances these behaviors. Corresponding changes are observed in mesenchymal markers (Vimentin, β-catenin, Snail, Slug) and the epithelial marker T-cadherin, indicating that PCIF1 suppresses epithelial-to-mesenchymal transition (EMT)-mediated glioma invasion. Mechanistically, PCIF1 modulates the AKT pathway by promoting proteasomal degradation of AKT while increasing phosphorylated AKT (p-AKT) levels, revealing a complex regulatory mechanism. PCIF1 knockdown upregulates INPP5B, a lipid phosphatase, causing accumulation of PI(3,4)P2 and enhanced AKT activation. Conversely, PCIF1 overexpression increases PI(3,4,5)P3 production, elevating p-AKT levels. This bidirectional regulation suggests that PCIF1 influences phosphoinositide signaling and AKT activation. Our findings highlight PCIF1 as a key modulator of glioblastoma cell migration and invasion through phosphoinositide signaling, positioning it as a potential biomarker and therapeutic target in glioma.
Insights
Phosphorylated CTD Interacting Factor 1 (PCIF1) suppresses glioma cell migration and invasion by regulating the AKT pathway and epithelial-to-mesenchymal transition. PCIF1 acts as a tumor suppressor, offering potential therapeutic targets for glioblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Phosphorylated CTD Interacting Factor 1 (PCIF1) is crucial for mRNA m6Am modification.
- Previous studies established PCIF1 as a glioma tumor suppressor, inhibiting proliferation and inducing apoptosis.
- The role of PCIF1 in glioma cell migration and invasion was previously unclear.
Purpose of the Study:
- To investigate the role of PCIF1 in regulating glioma cell migration and invasion.
- To elucidate the molecular mechanisms underlying PCIF1's effects on glioma invasion.
- To explore PCIF1's potential as a therapeutic target in glioblastoma.
Main Methods:
- Overexpression and knockdown of PCIF1 in glioma cells.
- Assessment of cell migration and invasion assays.
- Analysis of epithelial-to-mesenchymal transition (EMT) markers (Vimentin, β-catenin, Snail, Slug, T-cadherin).
- Investigation of the AKT signaling pathway and phosphoinositide metabolism (PI(3,4)P2, PI(3,4,5)P3).
Main Results:
- PCIF1 overexpression inhibited glioma cell migration and invasion.
- PCIF1 knockdown enhanced migration and invasion, correlating with EMT marker changes.
- PCIF1 modulated AKT pathway activity through complex regulation of AKT and p-AKT levels.
- PCIF1 influenced phosphoinositide signaling, affecting AKT activation via INPP5B.
Conclusions:
- PCIF1 suppresses EMT-mediated glioma invasion.
- PCIF1 regulates glioblastoma cell migration and invasion via phosphoinositide signaling and AKT pathway modulation.
- PCIF1 is a potential biomarker and therapeutic target for glioma.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway
IP3/DAG Signaling Pathway
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
